- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
This statistic depicts the spending of the U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017. Spending on research and development of the U.S. pharmaceutical industry (PhRMA members) amounted to around 14.4 percent of total revenues in 1990.
Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
| Percentage of total revenue | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Percentage of total revenue | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic depicts the spending of the U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017. Spending on research and development of the U.S. pharmaceutical industry (PhRMA members) amounted to around 14.4 percent of total revenues in 1990.
Show more- Show sources information
- Show publisher information
- Release date
- June 2018
- Region
- United States
- Survey time period
- 1990 to 2017
- Special properties
- PhRMA members
- Supplementary notes
-
* Estimated.
** 2007 revised with more current data. - Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- June 2018
More information
- Region
- United States
- Survey time period
- 1990 to 2017
- Special properties
- PhRMA members
- Supplementary notes
-
* Estimated.
** 2007 revised with more current data. - Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
U.S. pharmaceutical industry
- 110 page/s
- English
- pptx
- Detailed references
Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "U.S. pharmaceutical industry"
- Contribution to global pharma
The most important statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2017*Market share of the leading 10 global pharmaceutical markets 2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018Leading countries in life sciences sector M&As 2018
- Overview
The most important statistics
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Companies
The most important statistics
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2018 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2018
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)Merck & Co - total revenue 2006-2018
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016
- Research and development
The most important statistics
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014R&D expenditure per employee in U.S. sectors 2000-2014
- Generics
The most important statistics
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*Spending change on branded and generic medicines in the U.S. 2013-2017
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2017
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
- Outlook
The most important statistics
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
- Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2019
- The consumer's view
The most important statistics
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. pharmaceutical industry spending on research and development 1990-2017
- Increase in research collaborations between 2005 and 2014 U.S. by type
- Pharmaceutical industry: EU trade partners in import 2010-2017
- U.S. human and veterinary pharmaceuticals - R&D spending 2017
- China's pharmaceutical market distribution 2011
- Brazil: Hypera Pharma's ad spending H1 2016-2017
- Top 50 pharmaceutical companies by prescription sales and R&D spending 2012
- Availability of new medicines in selected countries 2013
- Brazil: Ultrafarma's advertising spending 2016-2017
- Share value of the generic pharmaceuticals market in Turkey 2008-2016
- Projected 2020 revenue for top drugs approved in U.S. 2015
- Willingness of Chinese consumers to pay more for international medicine brands 2013
- Merck KGaA's revenue by segment 2014-2018
- Pharmaceutical sales worldwide 2007-2018
- Number of orphan drugs used in Norway 2016-2018
- United Kingdom (UK): pharmaceutical products export value to Slovenia 2012-2017
- United Kingdom (UK): pharmaceutical products import value from Denmark 2012-2017
- Sales value of sex hormones and modulators of the genital system in Spain 2004-2014
- United Kingdom (UK): pharmaceutical products export value to Austria 2012-2017
- Sales value of agents acting on the musculo-skeletal system in Spain 2004-2015
Studies
- Biotechnology Industry in Europe
- Pharmaceutical industry in Italy
- Putting the Science back into Life Sciences
- Unleashing Pharma from the R&D Value Chain
- 2018 PhRMA Annual Membership Survey
- The 2018 Genentech Oncology Trend Report
- Life Sciences Outlook United States 2017
- Global Participation in Clinical Trials Report 2015-2016
- The 2017 Genentech Oncology Trend Report
- Pharmaceutical trends in Europe
- Animal testing in the United Kingdom
- The Changing Face of Global Clinical Trials
- Pharmaceutical industry in the Netherlands
- 2015 Global life sciences outlook
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
Statistics on "U.S. pharmaceutical industry"
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Market share of top 10 national pharmaceutical markets worldwide in 2017*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Number of new molecular entities launched in the U.S. from 2003 to 2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by region
- Forecast of global medicine spending distribution in 2020, by region*
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)
- How is your overall impression of the U.S. pharma industry?
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?
- How would you rate the U.S. pharma companies concerning the quality of their drugs?
- How would you rate the U.S. pharma companies concerning their fairness towards patients?
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017
- Which of these pharma companies do you prefer when buying drugs?
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*
- Spending of the U.S. pharmaceutical industry on research and development at home and abroad from 1990 to 2017 (in million U.S. dollars)*
- Increase in biopharmaceutical research collaborations in the U.S. comparing 2005 and 2014, by type
- Distribution of EU pharmaceutical imports by major countries of origin from 2010 to 2017
- Spending on human and veterinary pharmaceutical R&D in the U.S. in 2017 (in million U.S. dollars)
- China's pharmaceutical market distribution in 2011
- Advertising spending of Hypera Pharma in Brazil in 1st half 2016 and 2017 (in million Brazilian reals)
- Global top 50 pharmaceutical companies by prescription sales and R&D spending in 2012 (in billion U.S. dollars)
- Global new molecular entities availability in selected countries in 2013*
- Advertising spending of Ultrafarma in Brazil in 1st half 2016 and 2017 (in million Brazilian reals)
- Market share of generic pharmaceuticals in Turkey from 2008 to 2016
- Projected 2020 revenue for top drugs approved in the U.S. in 2015 (in billion U.S. dollars)
- Willingness of Chinese consumers to pay extra for international medicine brands in 2013
- Merck KGaA's revenue from 2014 to 2018, by segment (in million euros)*
- Total global pharmaceutical sales from 2007 to 2018 (in billion British pounds)
- Number of orphan drugs used in Norway from 2016 to 2018
- Value of pharmaceutical products exported from the United Kingdom (UK) to Slovenia from 2012 to 2017 (in thousand U.S. dollars)
- Value of pharmaceutical products imported into the United Kingdom (UK) from Denmark from 2012 to 2017 (in million U.S. dollars)
- Total value of sex hormones and modulators of the genital system pharmaceutical sales in Spain from 2004 to 2014 (in million euros)
- Value of pharmaceutical products exported from the United Kingdom (UK) to Austria from 2012 to 2017 (in million U.S. dollars)
- Total sales value of agents acting on the musculo-skeletal system in Spain from 2004 to 2015 (in million euros)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.